Insider Trading Alert - VNTV, PVR, BSX, MDSO And SRE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 8, 2014, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,000.20 to $12,860,510.00.

Highlighted Stocks Traded by Insiders:

Vantiv (VNTV) - FREE Research Report

Greene Nelson F who is Chief Legal Officer & Sec. at Vantiv sold 12,494 shares at $32.09 on Jan. 8, 2014. Following this transaction, the Chief Legal Officer & Sec. owned 37,482 shares meaning that the stake was reduced by 25% with the 12,494-share transaction.

Weingart William J who is President, E-Commerce at Vantiv sold 5,891 shares at $32.14 on Jan. 8, 2014. Following this transaction, the President, E-Commerce owned 154,210 shares meaning that the stake was reduced by 3.68% with the 5,891-share transaction.

The shares most recently traded at $32.26, up $0.12, or 0.38% since the insider transaction. Historical insider transactions for Vantiv go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 15.1 million
  • 24-Week # shares sold: 30.2 million

The average volume for Vantiv has been 1.9 million shares per day over the past 30 days. Vantiv has a market cap of $4.7 billion and is part of the services sector and diversified services industry. Shares are down 1.47% year-to-date as of the close of trading on Wednesday.

Vantiv, Inc. provides electronic integrated payment processing services in the United States. It operates in two segments, Merchant Services and Financial Institution Services. The company has a P/E ratio of 37.8. Currently there are 10 analysts that rate Vantiv a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VNTV - FREE

TheStreet Quant Ratings rates Vantiv as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and weak operating cash flow. Get the full Vantiv Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

PVR Partners (PVR) - FREE Research Report

Van Roden John C Jr who is Director at PVR Partners sold 500 shares at $26.62 on Jan. 8, 2014. Following this transaction, the Director owned 4,543 shares meaning that the stake was reduced by 9.91% with the 500-share transaction.

Weller Jonathan B who is Director at PVR Partners sold 500 shares at $26.69 on Jan. 8, 2014. Following this transaction, the Director owned 5,503 shares meaning that the stake was reduced by 8.33% with the 500-share transaction.

The shares most recently traded at $26.25, down $0.44, or 1.68% since the insider transaction. Historical insider transactions for PVR Partners go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares sold: 3,245

The average volume for PVR Partners has been 490,600 shares per day over the past 30 days. PVR Partners has a market cap of $2.7 billion and is part of the basic materials sector and energy industry. Shares are down 1.94% year-to-date as of the close of trading on Wednesday.

PVR Partners, L.P. engages in the gathering and processing of natural gas; and management of coal and natural resource properties in the United States. The company operates in three segments: Eastern Midstream, Midcontinent Midstream, and Coal and Natural Resource Management. The stock currently has a dividend yield of 8.23%. Currently there are 2 analysts that rate PVR Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PVR - FREE

TheStreet Quant Ratings rates PVR Partners as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full PVR Partners Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Boston Scientific (BSX) - FREE Research Report

Mario Ernest who is Director at Boston Scientific sold 10,000 shares at $12.50 on Jan. 8, 2014. Following this transaction, the Director owned 374,959 shares meaning that the stake was reduced by 2.6% with the 10,000-share transaction.

The shares most recently traded at $12.74, up $0.24, or 1.88% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 360,902
  • 24-Week # shares sold: 458,275

The average volume for Boston Scientific has been 11.9 million shares per day over the past 30 days. Boston Scientific has a market cap of $16.6 billion and is part of the health care sector and health services industry. Shares are up 6.41% year-to-date as of the close of trading on Wednesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Medidata Solutions (MDSO) - FREE Research Report

Sherif Tarek who is Chairman & CEO at Medidata Solutions sold 20,000 shares at $59.44 on Jan. 8, 2014. Following this transaction, the Chairman & CEO owned 812,718 shares meaning that the stake was reduced by 2.4% with the 20,000-share transaction.

The shares most recently traded at $60.32, up $0.88, or 1.45% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares sold: 2,274
  • 12-Week # shares sold: 180,332
  • 24-Week # shares sold: 236,879

The average volume for Medidata Solutions has been 486,300 shares per day over the past 30 days. Medidata Solutions has a market cap of $3.2 billion and is part of the technology sector and computer software & services industry. Shares are up 0.43% year-to-date as of the close of trading on Wednesday.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company has a P/E ratio of 137.6. Currently there are 5 analysts that rate Medidata Solutions a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings rates Medidata Solutions as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Medidata Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sempra Energy (SRE) - FREE Research Report

Reed Debra L who is Chairman and CEO at Sempra Energy sold 27,776 shares at $86.98 on Jan. 8, 2014. Following this transaction, the Chairman and CEO owned 57,389 shares meaning that the stake was reduced by 32.61% with the 27,776-share transaction.

Rowland G Joyce who is Senior VP at Sempra Energy sold 9,681 shares at $86.98 on Jan. 8, 2014. Following this transaction, the Senior VP owned 0 shares meaning that the stake was reduced by 100% with the 9,681-share transaction.

Snell Mark A who is President at Sempra Energy sold 25,180 shares at $86.98 on Jan. 8, 2014. Following this transaction, the President owned 60,904 shares meaning that the stake was reduced by 29.25% with the 25,180-share transaction.

Householder Joseph A who is Executive VP and CFO at Sempra Energy sold 11,648 shares at $86.98 on Jan. 8, 2014. Following this transaction, the Executive VP and CFO owned 33,572 shares meaning that the stake was reduced by 25.76% with the 11,648-share transaction.

The shares most recently traded at $90.09, up $3.11, or 3.45% since the insider transaction. Historical insider transactions for Sempra Energy go as follows:

  • 12-Week # shares sold: 955
  • 24-Week # shares sold: 1,223

The average volume for Sempra Energy has been 1.1 million shares per day over the past 30 days. Sempra Energy has a market cap of $22.1 billion and is part of the utilities sector and utilities industry. Shares are down 0.02% year-to-date as of the close of trading on Wednesday.

Sempra Energy, through its subsidiaries, operates as an energy services company. The company's San Diego Gas & Electric Company segment is involved in the generation, transmission, and distribution electricity; and sale, distribution, and transportation of natural gas in California. The stock currently has a dividend yield of 2.78%. The company has a P/E ratio of 22.3. Currently there are 6 analysts that rate Sempra Energy a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SRE - FREE

TheStreet Quant Ratings rates Sempra Energy as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, notable return on equity and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Sempra Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet